894 related articles for article (PubMed ID: 27395059)
21. Antiosteoporotic activity of Du-Zhong-Wan water extract in ovariectomized rats.
Li F; Yang X; Bi J; Yang Z; Zhang C
Pharm Biol; 2016 Sep; 54(9):1857-64. PubMed ID: 26760929
[TBL] [Abstract][Full Text] [Related]
22. Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats.
Wang L; Orhii PB; Banu J; Kalu DN
Bone; 2001 Feb; 28(2):202-7. PubMed ID: 11182379
[TBL] [Abstract][Full Text] [Related]
23. Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.
Leder BZ; O'Dea LS; Zanchetta JR; Kumar P; Banks K; McKay K; Lyttle CR; Hattersley G
J Clin Endocrinol Metab; 2015 Feb; 100(2):697-706. PubMed ID: 25393645
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model.
Søgaard CH; Mosekilde L; Thomsen JS; Richards A; McOsker JE
Bone; 1997 May; 20(5):439-49. PubMed ID: 9145241
[TBL] [Abstract][Full Text] [Related]
25. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
26. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
Sato M; Westmore M; Ma YL; Schmidt A; Zeng QQ; Glass EV; Vahle J; Brommage R; Jerome CP; Turner CH
J Bone Miner Res; 2004 Apr; 19(4):623-9. PubMed ID: 15005850
[TBL] [Abstract][Full Text] [Related]
27. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
28. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
29. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
[TBL] [Abstract][Full Text] [Related]
30. Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats.
Yao W; Hadi T; Jiang Y; Lotz J; Wronski TJ; Lane NE
Osteoporos Int; 2005 Dec; 16(12):1939-47. PubMed ID: 16086094
[TBL] [Abstract][Full Text] [Related]
31. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats.
Saino H; Matsuyama T; Takada J; Kaku T; Ishii S
J Bone Miner Res; 1997 Nov; 12(11):1844-50. PubMed ID: 9383689
[TBL] [Abstract][Full Text] [Related]
32. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
Wang L; Orhii PB; Banu J; Kalu DN
Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
[TBL] [Abstract][Full Text] [Related]
33. Mechanical Vibration Associated With Intermittent PTH Improves Bone Microarchitecture in Ovariectomized Rats.
Campos JF; Mierzwa AGH; Freitas-Jesus M; Lazaretti-Castro M; Nonaka KO; Reginato RD
J Clin Densitom; 2020; 23(3):511-519. PubMed ID: 30327242
[TBL] [Abstract][Full Text] [Related]
34. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD
Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783
[TBL] [Abstract][Full Text] [Related]
35. Positive skeletal effects of cladrin, a naturally occurring dimethoxydaidzein, in osteopenic rats that were maintained after treatment discontinuation.
Khan K; Sharan K; Swarnkar G; Chakravarti B; Mittal M; Barbhuyan TK; China SP; Khan MP; Nagar GK; Yadav D; Dixit P; Maurya R; Chattopadhyay N
Osteoporos Int; 2013 Apr; 24(4):1455-70. PubMed ID: 22932734
[TBL] [Abstract][Full Text] [Related]
36. Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration.
Kishi T; Hagino H; Kishimoto H; Nagashima H
Bone; 1998 May; 22(5):515-22. PubMed ID: 9600786
[TBL] [Abstract][Full Text] [Related]
37. Teriparatide and Abaloparatide Have a Similar Effect on Bone in Mice.
Brent MB; Stoltenborg FE; Brüel A; Thomsen JS
Front Endocrinol (Lausanne); 2021; 12():628994. PubMed ID: 33953694
[TBL] [Abstract][Full Text] [Related]
38. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
39. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
[TBL] [Abstract][Full Text] [Related]
40. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
Wang ML; Massie J; Perry A; Garfin SR; Kim CW
Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
